The DETECT Initiative in Early Alzheimer’s Disease:
Optimizing Collaboration and Multidisciplinary Care to Facilitate Timely Diagnosis
Podcast #3 - Neurologists
Pre-test
Exit Survey
Questions marked with a
*
are required
100%
Contact Information
First Name
Last Name
Email Address
Harry is a 61-year-old male attorney with 20 years of education. He has memory loss, difficulty concentrating, loses focus in the middle of important meetings, and exhibits a shortened attention span. He shows signs of depression, anxiety, and lack of insight. Lately he has become more impulsive and disinhibited, with increased hostility and selfishness. His primary care physician has referred him to you. He scores 29 out of 30 on the MMSE. An MRI showed hippocampal atrophy in the medial temporal lobe, but otherwise age-appropriate atrophy in the frontal, parietal, temporal, and occipital lobes. What is the next test you order?
CSF for P-tau
Amyloid PET scan
CT imaging
Based on the significantly high levels of amyloid seen on the PET scan, Harry is diagnosed with early onset Alzheimer’s disease. His genetic test returns positive for two copies of APOE4. Which therapy should be administered with great caution?
Aducanumab
Memantine
Cholinesterase inhibitors (ChEIs)
Done
Powered by
QuestionPro
Loading...
close
drag_indicator
close
Yes
Cancel
Continue
Answer Question
Continue Without Answering
Keep Data
Discard
close